Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
This bridge program will now allow Medicare beneficiaries access to GLP-1 medications for weight loss through a monthly subscription model, which raises important questions about who pays, how much it will cost, and whether the program can be sustained long term, Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek
Time alone is sufficient reason
Across these studies, semaglutide 2.4 mg (the dose used for weight management) showed consistent and significant weight-loss results
Even at doses exceeding 200 times the effective amount for GH release, Ipamorelin produced no significant elevation in ACTH or cortisol levels
Semaglutide users navigating this landscape need to separate genuine quality indicators from marketing noise
At one injection per week, these risks are minimal
